ReviewBiosensors2025
Recent Advances in MXene-Based Screen-Printed Electrochemical Sensors for Point-of-Care Biomarker Detections.
Review in Biosensors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Next generation smart functionalized nanocomposites for ultrasensitive and real time detection of purine derived metabolic biomarkers.RSC advances · 2026Review
- A Novel 3D-Printed Flow Cell Design forMicromachines · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Contemporary biomedical diagnostics increasingly demand high sensitivity for pathogen detection and real-time health monitoring. In response to these requirements, screen-printed electrochemical sensors (SPEs) have emerged as a practical analytical platform owing to their low cost, portability, and compatibility with point-of-care and wearable systems. In the recent past, nanomaterials in two-dimensional format, especially MXenes, have gained much interest due to their high electrical conductivity, controllable surface chemistry, and biocompatibility, which can improve the performance and applicability of SPEs. The current review concentrates on the latest developments between 2020 and 2025, providing a critical assessment of research employing MXene-based nanomaterials for the modification and development of screen-printed electrode platforms. We provide an overview of fabrication techniques, printing methods, and surface modification methods, and proceed with an analysis of the electrochemical performance of MXenes and MXene-based heterostructures. Lastly, contemporary issues are considered, and opinions are suggested to facilitate the translation of MXene-functionalized SPEs to real biomedical diagnosis solutions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.